Hazhir Teymourian
Overview
Explore the profile of Hazhir Teymourian including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
893
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wu Y, Tehrani F, Teymourian H, Mack J, Shaver A, Reynoso M, et al.
Anal Chem
. 2023 Sep;
95(39):14830-14831.
PMID: 37733932
No abstract available.
2.
Teymourian H, Tehrani F, Longardner K, Mahato K, Podhajny T, Moon J, et al.
Nat Rev Neurol
. 2022 Jun;
18(8):497-507.
PMID: 35681103
Although levodopa remains the most efficacious symptomatic therapy for Parkinson disease (PD), management of levodopa treatment during the advanced stages of the disease is extremely challenging. This difficulty is a...
3.
Wu Y, Tehrani F, Teymourian H, Mack J, Shaver A, Reynoso M, et al.
Anal Chem
. 2022 Jun;
94(23):8335-8345.
PMID: 35653647
The ability to continuously monitor the concentration of specific molecules in the body is a long-sought goal of biomedical research. For this purpose, interstitial fluid (ISF) was proposed as the...
4.
Tehrani F, Teymourian H, Wuerstle B, Kavner J, Patel R, Furmidge A, et al.
Nat Biomed Eng
. 2022 May;
6(11):1214-1224.
PMID: 35534575
Implementations of wearable microneedle-based arrays of sensors for the monitoring of multiple biomarkers in interstitial fluid have lacked system integration and evidence of robust analytical performance. Here we report the...
5.
Xu N, Nguyen K, DuBord A, Pickup J, Sherr J, Teymourian H, et al.
J Diabetes Sci Technol
. 2022 May;
16(4):1016-1056.
PMID: 35499170
Diabetes Technology Society hosted its annual Diabetes Technology Meeting on November 4 to November 6, 2021. This meeting brought together speakers to discuss various developments within the field of diabetes...
6.
Aiello E, Pinsker J, Vargas E, Teymourian H, Tehrani F, Church M, et al.
J Diabetes Sci Technol
. 2022 Feb;
17(4):1038-1048.
PMID: 35118893
Background: The estimation of available active insulin remains a limitation of automated insulin delivery systems. Currently, insulin pumps calculate active insulin using mathematical decay curves, while quantitative measurements of insulin...
7.
Vargas E, Aiello E, Pinsker J, Teymourian H, Tehrani F, Church M, et al.
J Diabetes Sci Technol
. 2022 Jan;
17(4):1029-1037.
PMID: 35043720
Background: Clinical decision support systems that incorporate information from frequent insulin measurements to enhance individualized diabetes management remain an unmet goal. The development of a disposable insulin strip for fast...
8.
S Sandhu S, Kotagiri Y, Fernando I P, Kalaj M, Tostado N, Teymourian H, et al.
J Am Chem Soc
. 2021 Oct;
143(43):18261-18271.
PMID: 34677965
Rapid and robust sensing of nerve agent (NA) threats is necessary for real-time field detection to facilitate timely countermeasures. Unlike conventional phosphotriesterases employed for biocatalytic NA detection, this work describes...
9.
Moon J, Teymourian H, De la Paz E, Sempionatto J, Mahato K, Sonsa-Ard T, et al.
Angew Chem Int Ed Engl
. 2021 Jun;
60(35):19074-19078.
PMID: 34145703
Levodopa (L-Dopa) is the "gold-standard" medication for symptomatic therapy of Parkinson disease (PD). However, L-Dopa long-term use is associated with the development of motor and non-motor complications, primarily due to...
10.
Wolkowicz K, Aiello E, Vargas E, Teymourian H, Tehrani F, Wang J, et al.
Bioeng Transl Med
. 2021 May;
6(2):e10201.
PMID: 34027090
As wearable healthcare monitoring systems advance, there is immense potential for biological sensing to enhance the management of type 1 diabetes (T1D). The aim of this work is to describe...